Combined burden and functional impact tests for cancer driver discovery using DriverPower.

Shuai, Shimin; Gallinger, Steven; Stein, Lincoln (2020). Combined burden and functional impact tests for cancer driver discovery using DriverPower. Nature communications, 11(1), p. 734. Nature Publishing Group 10.1038/s41467-019-13929-1

[img]
Preview
Text
41467_2019_Article_13929.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (692kB) | Preview

The discovery of driver mutations is one of the key motivations for cancer genome sequencing. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2658 cancers across 38 tumour types, we describe DriverPower, a software package that uses mutational burden and functional impact evidence to identify driver mutations in coding and non-coding sites within cancer whole genomes. Using a total of 1373 genomic features derived from public sources, DriverPower's background mutation model explains up to 93% of the regional variance in the mutation rate across multiple tumour types. By incorporating functional impact scores, we are able to further increase the accuracy of driver discovery. Testing across a collection of 2583 cancer genomes from the PCAWG project, DriverPower identifies 217 coding and 95 non-coding driver candidates. Comparing to six published methods used by the PCAWG Drivers and Functional Interpretation Working Group, DriverPower has the highest F1 score for both coding and non-coding driver discovery. This demonstrates that DriverPower is an effective framework for computational driver discovery.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Präzisionsonkologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Präzisionsonkologie

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2041-1723

Publisher:

Nature Publishing Group

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

31 Aug 2020 17:37

Last Modified:

13 Mar 2021 12:41

Publisher DOI:

10.1038/s41467-019-13929-1

PubMed ID:

32024818

Additional Information:

Collaborator PCAWG Drivers and Functional Interpretation Working Group: Johnson, Rory
Collaborator from the DBMR: Mark A Rubin (Director DBMR, Precision Medicine)

BORIS DOI:

10.7892/boris.146115

URI:

https://boris.unibe.ch/id/eprint/146115

Actions (login required)

Edit item Edit item
Provide Feedback